LOGIN  |  REGISTER
Viking Therapeutics

List of Healthcare Stocks

Company
Last Trade
Change
Volume
Shares Out
Market Cap
US$ 296.45
-6.53 -2.16
26.65M
920.28M
US$ 272.820B
US$ 376.64
-5.17 -1.35
1.24M
253.30M
US$ 95.400B
US$ 384.51
-15.61 -3.90
1.91M
231.92M
US$ 89.180B
US$ 312.68
-4.41 -1.39
1.59M
278.15M
US$ 86.970B
US$ 60.41
-1.70 -2.74
9.39M
1.26B
US$ 76.120B
US$ 235.53
0.53 0.23
1.05M
162.35M
US$ 38.240B
US$ 69.44
-0.14 -0.20
2.75M
456.87M
US$ 31.730B
US$ 58.07
-2.67 -4.40
4.24M
504.86M
US$ 29.320B
US$ 227.14
-18.63 -7.58
2.95M
120.41M
US$ 27.350B
US$ 309.77
-9.85 -3.08
892,645
57.20M
US$ 17.720B
US$ 29.32
-0.48 -1.61
398,613
586.83M
US$ 17.210B
US$ 161.33
-1.50 -0.92
845,376
95.10M
US$ 15.340B
US$ 72.66
-0.10 -0.14
1.07M
172.76M
US$ 12.550B
US$ 118.61
-1.24 -1.03
467,641
100.75M
US$ 11.950B
US$ 138.52
-2.33 -1.65
611,168
82.02M
US$ 11.360B
US$ 186.65
-3.50 -1.84
419,933
58.71M
US$ 10.960B
US$ 11.24
0.06 0.54
5.35M
864.15M
US$ 9.710B
US$ 100.08
1.28 1.30
1.76M
86.66M
US$ 8.670B
US$ 561.44
-9.78 -1.71
132,116
14.98M
US$ 8.410B
US$ 144.65
-1.41 -0.97
224,020
57.30M
US$ 8.290B
US$ 51.26
0.51 1.00
2.64M
128.14M
US$ 6.570B
US$ 38.20
-1.10 -2.80
1.41M
172.09M
US$ 6.570B
US$ 14.31
0.00 0.00
0
422.39M
US$ 6.040B
US$ 32.03
-0.68 -2.08
1.19M
170.18M
US$ 5.450B
US$ 22.92
-0.82 -3.45
1.76M
174.13M
US$ 3.990B
US$ 14.65
-0.21 -1.41
8.41M
211.76M
US$ 3.100B
US$ 93.56
-0.03 -0.03
161,502
32.75M
US$ 3.060B
US$ 22.60
-0.07 -0.31
645,071
127.11M
US$ 2.870B
US$ 14.49
-0.84 -5.48
3.75M
191.70M
US$ 2.780B
US$ 23.10
-0.70 -2.94
831,846
120.00M
US$ 2.770B
US$ 23.20
0.14 0.61
1.58M
96.11M
US$ 2.230B
US$ 5.63
-0.04 -0.71
1.17M
382.64M
US$ 2.150B
US$ 22.96
-5.73 -19.97
1.53M
92.89M
US$ 2.130B
US$ 14.80
-0.14 -0.94
260,090
142.73M
US$ 2.110B
US$ 111.53
13.49 13.76
212,316
18.13M
US$ 2.020B
US$ 14.49
-0.26 -1.76
1.69M
128.99M
US$ 1.870B
US$ 11.48
0.31 2.78
1.58M
160.99M
US$ 1.850B
US$ 67.33
-0.45 -0.66
696,728
27.47M
US$ 1.850B
US$ 20.89
-0.30 -1.42
804,722
85.15M
US$ 1.780B
US$ 101.59
-1.69 -1.64
25,498
15.44M
US$ 1.570B
US$ 9.80
-0.08 -0.81
294,220
155.18M
US$ 1.520B
US$ 22.58
0.52 2.36
146,453
63.29M
US$ 1.430B
US$ 24.34
-0.15 -0.61
423,756
58.12M
US$ 1.410B
US$ 3.30
-0.22 -6.25
8.77M
412.08M
US$ 1.360B
US$ 21.22
0.71 3.46
992,536
63.69M
US$ 1.350B
US$ 28.84
1.50 5.49
1.02M
46.32M
US$ 1.340B
US$ 6.42
-0.14 -2.13
2.73M
199.21M
US$ 1.280B
US$ 7.61
-0.20 -2.56
1,591
162.86M
US$ 1.240B
US$ 13.97
-1.20 -7.91
1.25M
85.88M
US$ 1.200B
US$ 6.90
-0.07 -1.00
5.96M
172.17M
US$ 1.190B
US$ 75.40
-1.88 -2.43
104,522
15.10M
US$ 1.140B
US$ 24.47
-0.72 -2.86
407,512
45.65M
US$ 1.120B
US$ 14.28
-0.22 -1.52
399,883
73.29M
US$ 1.050B
US$ 5.35
-0.14 -2.55
315,685
193.22M
US$ 1.030B
C$ 4.09
0.03 0.74
531,522
248.96M
C$ 1.020B
US$ 28.06
-0.57 -1.99
109,957
34.35M
US$ 963.860M
US$ 8.54
0.22 2.64
2.58M
107.00M
US$ 913.780M
US$ 2.20
-0.15 -6.38
13.83M
412.02M
US$ 906.440M
US$ 161.86
-7.14 -4.22
137,527
5.44M
US$ 880.520M
US$ 7.36
-0.64 -8.00
2.93M
115.03M
US$ 846.620M
US$ 27.82
-0.42 -1.49
314,690
30.41M
US$ 846.010M
US$ 21.67
-0.44 -1.99
391,188
38.07M
US$ 824.980M
US$ 32.49
0.79 2.49
278,616
20.09M
US$ 652.720M
US$ 6.89
0.00 0.00
0
81.68M
US$ 562.780M
C$ 10.42
0.13 1.26
161,092
52.61M
C$ 548.200M
US$ 4.02
-0.08 -1.95
15,471
135.46M
US$ 544.550M
US$ 1.43
0.00 0.00
0
371.88M
US$ 531.790M
US$ 3.72
-0.23 -5.82
2.30M
138.95M
US$ 516.890M
US$ 10.26
-0.17 -1.63
198,557
50.28M
US$ 515.870M
US$ 29.20
0.00 0.00
0
16.17M
US$ 472.160M
US$ 24.63
-0.13 -0.53
26,101
19.07M
US$ 469.690M
US$ 2.76
-0.15 -4.99
1.90M
168.92M
US$ 466.220M
US$ 4.20
0.00 0.00
0
107.64M
US$ 452.090M
US$ 3.78
-0.01 -0.26
778,210
104.27M
US$ 394.140M
C$ 15.47
0.07 0.45
12,223
23.40M
C$ 362.000M
US$ 3.13
-0.01 -0.32
644,954
115.52M
US$ 361.580M
US$ 23.69
-0.46 -1.90
165,578
14.93M
US$ 353.690M
US$ 16.19
-0.34 -2.06
149,260
20.27M
US$ 328.170M
US$ 4.16
0.24 6.12
728,681
57.88M
US$ 240.780M
C$ 1.40
0.02 1.45
154,640
165.88M
C$ 232.230M
US$ 2.99
0.32 11.78
1.80M
75.56M
US$ 225.920M
US$ 12.09
0.48 4.13
216,806
18.42M
US$ 222.700M
US$ 3.66
-0.09 -2.41
391,287
60.85M
US$ 222.410M
US$ 6.81
-0.03 -0.44
20,030
30.00M
US$ 204.300M
US$ 2.89
-0.04 -1.37
20,055
66.44M
US$ 192.010M
C$ 2.86
0.04 1.42
104,630
63.49M
C$ 181.580M
US$ 6.02
0.00 0.00
0
27.08M
US$ 163.020M
US$ 6.98
6.23 830.67
6,349
23.12M
US$ 161.380M
US$ 10.05
0.04 0.40
47,284
14.98M
US$ 150.550M
US$ 24.94
2.11 9.24
10.17M
5.98M
US$ 149.140M
US$ 3.67
-0.13 -3.42
35,990
37.15M
US$ 136.340M
US$ 1.34
0.06 4.69
2.82M
101.53M
US$ 136.050M
US$ 3.75
-0.12 -3.10
65,958
31.11M
US$ 116.660M
US$ 2.35
0.00 0.00
0
49.43M
US$ 116.160M
US$ 1.39
-0.01 -0.71
66,045
73.84M
US$ 102.640M
US$ 7.44
0.00 0.00
27,855
13.67M
US$ 101.700M
US$ 3.74
-0.08 -2.09
374,697
26.35M
US$ 98.550M
C$ 1.32
0.04 3.12
21,000
74.08M
C$ 97.790M
US$ 0.86
-0.01 -1.27
17,688
86.02M
US$ 73.810M
US$ 2.10
0.05 2.44
2,162
31.02M
US$ 65.140M
US$ 6.88
0.12 1.78
2,369
8.29M
US$ 57.040M
US$ 4.80
-0.05 -1.03
15,812
8.06M
US$ 38.690M
US$ 2.05
0.00 0.00
0
16.39M
US$ 33.600M
US$ 2.05
0.02 0.99
220,268
16.26M
US$ 33.330M
US$ 1.34
0.03 2.29
27,798
22.41M
US$ 30.030M
US$ 1.17
-0.13 -9.69
1,124
24.67M
US$ 28.740M
US$ 7.88
0.07 0.90
268
2.82M
US$ 22.220M
C$ 0.25
0.00 0.00
0
86.21M
C$ 21.120M
C$ 0.32
0.00 0.00
0
59.14M
C$ 18.630M
US$ 1.25
-0.05 -3.85
33,817
14.36M
US$ 17.950M
US$ 0.21
0.00 0.00
0
82.96M
US$ 17.180M
US$ 1.85
0.01 0.54
66,034
8.71M
US$ 16.110M
US$ 2.35
-0.04 -1.67
17,735
6.42M
US$ 15.090M
US$ 0.89
0.00 0.00
279,620
14.28M
US$ 12.710M
C$ 0.23
0.00 0.00
45,000
56.40M
C$ 12.690M
C$ 0.13
0.00 0.00
0
93.47M
C$ 11.680M
US$ 0.41
0.02 6.28
182,644
27.99M
US$ 11.420M
US$ 2.18
-0.02 -0.91
4,055
4.27M
US$ 9.310M
US$ 1.57
0.01 0.64
24,347
4.22M
US$ 6.630M
US$ 0.86
0.009 1.06
27,563
7.04M
US$ 6.050M
C$ 0.04
0.00 0.00
0
133.13M
C$ 5.330M
US$ 2.77
0.00 0.00
0
1.88M
US$ 5.220M
US$ 1.69
0.21 14.19
155,022
2.49M
US$ 4.210M
C$ 0.07
-0.02 -17.65
68,500
55.51M
C$ 3.890M
US$ 0.29
0.00 0.00
0
12.75M
US$ 3.660M
US$ 0.83
-0.96 -53.63
1,856
4.22M
US$ 3.500M
US$ 0.42
0.00 0.00
0
3.81M
US$ 1.610M
C$ 0.19
0.00 0.00
0
6.40M
C$ 1.180M
US$ 0.11
0.0057 5.47
5,791
8.97M
US$ 987K
C$ 0.02
0.00 0.00
0
47.62M
C$ 952K
C$ 0.01
0.00 0.00
0
89.59M
C$ 896K
US$ 0.28
0.00 0.00
0
3.13M
US$ 876K
C$ 0.005
0.00 0.00
0
173.26M
C$ 866K
US$ 0.40
-0.02 -4.29
128,053
1.86M
US$ 748K
C$ 0.005
0.00 0.00
0
87.10M
C$ 436K
US$ 0.008
0.00 0.00
0
37.67M
US$ 301K
US$ 0.005
0.00 0.00
0
19.73M
US$ 99K
US$ 0.007
-0.001 -12.50
259.28M
5.67M
US$ 40K
US$ 0.00
0.00 0.00
0
-
US$ -

Latest Healthcare Stock News


Claritev and Burjeel Holdings Finalize Strategic Collaboration, Marks Claritev’s Expansion into the Middle East

This agreement follows the previous announcement of a memorandum of understanding signed last month. MCLEAN, Va. & ABU DHABI, United Arab Emirates / May 22, 2025 / Business Wire / Claritev Corporation (“Claritev”) (NYSE: CTEV) and Claims Care Revenue Cycle Management LLC (“Claims Care” or “CCRCM”), a division of Burjeel Holdings (ADX: BURJEEL), are pleased to announce the formalization of their strategic relationship, following the signing of a memorandum... Read more


Schrödinger to Present at Jefferies Global Healthcare Conference

NEW YORK / May 22, 2025 / Business Wire / Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference. The live presentation will take place on Wednesday, June 4, 2025 at 1:25 p.m. E.T. The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be archived for approximately 90 days following the event. About Schrödinger Schrödinger is transforming... Read more


GeneDx Publishes Pioneering Vision for Applying AI to Genomics to Improve and Expedite Diagnosis of Genetic Disease at Scale

Company deploying AI to scale industry-leading rare disease dataset to diagnose growing number of patients with genetic disease, published in the American Journal of Medical Genetics GAITHERSBURG, Md. / May 22, 2025 / Business Wire / GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the publication of a new article in the American Journal of Medical Genetics, demonstrating GeneDx’s leadership in applying... Read more


The Joint Corp. Announces Christopher M. Grandpre Elected as Director

Franchise and investment banking expert strengthens the board  SCOTTSDALE, Ariz., May 22, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network dedicated to revolutionizing access to chiropractic care and building a leading wellness franchise with a strong business model, announced Christopher M. Grandpre has been elected as a director to help enable the company in achieving... Read more


Doximity to Present at the William Blair 45th Annual Growth Stock Conference

SAN FRANCISCO / May 21, 2025 / Business Wire / Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Jeff Tangney, co-founder and CEO, will present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025 at 4:40 p.m. Central Time. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 80% of... Read more


Cigna: Evernorth Launches New Benefit Option That Drives Lower Net Cost for Weight Loss Medicines and Limits Patient Cost to No More Than $200 Per Month

Patients can save as much as $3600 per year versus direct-to-consumer manufacturer programs, and out of pocket cost applies to their annual deductible New offering helps employers meet growing demand for FDA-approved weight loss medications at a lower net cost per prescription while ensuring clinical safety for patients ST LOUIS, May 21, 2025  /PRNewswire/ -- Evernorth, the health services division of The Cigna Group (NYSE: CI) announced a first-of-its-kind pharmacy... Read more


Alignment Healthcare to Present at William Blair 45th Annual Growth Stock Conference

ORANGE, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the William Blair 45th Annual Growth Stock Conference on Wednesday, June 4, at 2 p.m. CDT. A webcast and replay of the presentations will be available on Alignment’s investor relations website at https://ir.alignmenthealth.com/. About Alignment Healthcare Alignment Health is championing a new path in senior care that empowers members to... Read more


Premier Health Reports 2025 Second Quarter Results

MONTRÉAL, May 21, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Company”), a leading Canadian Healthtech company, announces it has filed its unaudited Quarterly Consolidated Financial Statements and MD&A for its second quarter ended on March 31st, 2025. Highlights             Mar. 31, 2025   Mar. 31, 2024   Mar. 31, 2025   Mar. 31, 2024   (in thousands... Read more


Auna Announces 1Q25 Financial Results

Adjusted EBITDA increases 1% FXN YoY; Peru supports quarterly results, further validating its integrated business model LUXEMBOURG / May 20, 2025 / Business Wire / Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, today announced financial results for the first quarter ended March 31, 2025 (“first quarter 2025” or “1Q25”). Financial results are expressed in Peruvian... Read more


Walgreens Expands Micro-Fulfillment Network with New Facility in Brooklyn Park, Minnesota

The facility will support nearly 200 stores regionally with the dispensing and shipping of prescriptions, allowing pharmacists to spend more time with patients. DEERFIELD, Ill. / May 20, 2025 / Business Wire / Walgreens is continuing to invest in innovative pharmacy solutions with the opening of a new micro-fulfillment center (MFC) in Brooklyn Park, Minnesota. This facility will streamline prescription processing and reduce administrative tasks, freeing up pharmacists... Read more


DaVita Announces Offering of $750 Million Senior Notes

DENVER, May 20, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita") announced today that it has commenced a private offering (the "offering") of $750 million aggregate principal amount of its senior notes due 2033 (the "2033 notes"), subject to market and other conditions. DaVita intends to use the net proceeds from the offering (i) to repay outstanding revolving credit facility borrowings, together with related accrued and unpaid interest thereon, (ii) to pay... Read more


Mobile-health Network Solutions Signs MOU to Add AI-enabled Dental Scans and Oral Health Screening to its Telemedicine Platform

Singapore, Singapore--(Newsfile Corp. - May 20, 2025) - Mobile-health Network Solutions (Nasdaq: MNDR) ("MNDR" or "the Company"), a leading MedTech innovator ranked among Asia-Pacific's high-growth companies, today unveiled a new tele-dentistry service that is soon expected to let patients perform an AI-enhanced dental scan at home using the Company's MaNaDr telemedicine app, with expert-reviewed reports delivered within 24 hours. The service, which MNDR will market to... Read more


More Than 75 Emerging Biotechs Use Veeva Systems Basics Across Clinical, Regulatory, and Quality

Delivers pre-configured, pre-validated software that can scale with the needs of fast-growing companies PLEASANTON, Calif., May 20, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Veeva Basics is being used by more than 75 biotechs to gain efficiency and reduce costs across clinical, regulatory, and quality. With standardized applications, biotechs are going live with industry-leading software in weeks and gaining a system that can scale as they... Read more


Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site

USC Spine Center, part of Keck Medicine of USC, specializes in treating complex spine conditions with the latest cutting-edge technologies CLARITY is a randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) BROOMFIELD, Colo., May 20, 2025 (GLOBE NEWSWIRE)... Read more


Ontrak Health Announces 2025 First Quarter Financial Results

Q1 Revenue of $2.0 million, down 25% year over year Q1 Operating loss of $(5.9) million, a 37% increase year over year Q1 Adjusted EBITDA of $(4.3) million, a 28% decline year over year Company announces securing a $10.0 million financing commitment from Acuitas Capital LLC Company announces recertification by the National Committee for Quality Assurance (NCQA) as a Credentials Verification Organization (CVO) Company to Host Conference Call at 4:30 pm ET Today MIAMI... Read more


TruBridge Announces Next Step of Collaboration With Microsoft, Enhancing Community Healthcare Through Advanced Clinical Documentation Capabilities

MOBILE, Ala. / May 19, 2025 / Business Wire / TruBridge, Inc. (NASDAQ:TBRG), a leading healthcare solutions company, today announced the integration of Microsoft Dragon Copilot with its electronic health record (EHR) solution. Collaboration between the two technologies will enhance care delivery, financial stability, and operational efficiency for thousands of hospitals and health systems across the country. Microsoft Dragon Copilot will empower more than 18,000 TruBridge... Read more


Ardent Health Appoints Chief Development Officer to Lead Strategic Growth

BRENTWOOD, Tenn. / May 19, 2025 / Business Wire / Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Chris Schoeplein as chief development officer. In this new role, Schoeplein will lead development efforts across Ardent’s existing markets and support the organization’s expansion into new regions. He will be responsible for driving growth across inpatient and outpatient... Read more


Pennant Appoints Suzanne Snapper as Director

EAGLE, Idaho, May 16, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced the appointment of Suzanne D. Snapper to its board of directors following her election by a vote of shareholders in connection with the Company’s annual shareholder meeting. Ms. Snapper is the Chief Financial Officer of the Ensign Group, Inc. (“Ensign”) (NASDAQ:... Read more


So-Young Reports Unaudited First Quarter 2025 Financial Results

BEIJING, May 16, 2025 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced its unaudited financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Total revenues were RMB297.3 million (US$41.0 million[1]), compared with RMB318.3 million in... Read more


P3 Health Partners Announces First Quarter 2025 Results

 Affirming 2025 guidance Management to Host Conference Call and Webcast May 15, 2025 at 4:30 PM ET HENDERSON, Nev. / May 15, 2025 / Business Wire / P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the first quarter ended March 31, 2025, and affirmed its 2025 guidance. “Our physician-led care enablement model continues to... Read more


Doximity Announces Fourth Quarter and Fiscal Year 2025 Financial Results

Q4 total revenues of $138.3 million, up 17% year-over-year Q4 operating cash flow of $98.5 million, up 54% year-over-year Q4 free cash flow of $97.0 million, up 56% year-over-year Fiscal year 2025 total revenues of $570.4 million, up 20% year-over-year Fiscal year 2025 operating cash flow of $273.3 million, up 48% year-over-year Fiscal year 2025 free cash flow of $266.7 million, up 50% year-over-year SAN FRANCISCO / May 15, 2025 / Business Wire / Doximity, Inc.... Read more


Mobile-health Network Solutions to Present at Sidoti Virtual Investor Conference, May 21-22, and Virtual Tech Conference, June 3-5

Singapore, Singapore--(Newsfile Corp. - May 15, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or "the Company"), a leading MedTech innovator ranked among Asia-Pacific's high-growth companies, today announced it will present at two upcoming conferences. Co-CEOs and co-founders Dr. Tung Yeng Siaw and Dr. Rachel Teoh will present and host one-on-one meetings with investors at the Sidoti May Virtual Investor Conference, to be held May 21-22, 2025. Their... Read more


GE HealthCare launches CleaRecon DL, introducing AI-based 3D reconstruction to the interventional suite

CleaRecon DL receives 510(k) clearance and CE mark, paving the way for clinicians to use 3D image guidance technologies to their full potential with the goal of achieving better clinical and operational outcomes AI-driven solution advances image quality and improves clinical confidence, encouraging adoption of cone-beam computed tomography CHICAGO / May 15, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced the launch of CleaRecon DL, technology powered... Read more


Simulations Plus Releases DILIsym® 11

Newest version of the quantitative systems toxicology (QST) software supports drug-induced liver injury (DILI) prediction for pediatric patient populations RESEARCH TRIANGLE PARK, N.C. / May 15, 2025 / Business Wire / Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced the release... Read more


American Shared Hospital Services Reports First Quarter 2025 Financial Results

Reports 17% Year over Year First Quarter Revenue Growth Conference Call Scheduled for 12:00 PM ET Today SAN FRANCISCO, May 15, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its leasing and direct patient care services segments, today announced financial results for the first quarter ended March... Read more


Neupath Health Reports First Quarter 2025 Results

Record total revenue of $19.3 million, up 11% year-over-year Positive cash flows, with Adjusted EBITDA(1) of $1.3 million, up 49% year-over-year, and our 25th consecutive quarter of positive Adjusted EBITDA Secured new credit facilities to drive growth and to refinance existing debt On May 1, Stephen Lemieux assumed the role of President to lead the implementation of NeuPath’s strategic initiatives TORONTO / May 15, 2025 / Business Wire / NeuPath Health Inc. (TSXV:NPTH),... Read more


The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance

CERRITOS, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended March 31, 2025. Recent Operational Highlights Retail Pharmacy and Dispensary set fill records, contributing $49.3 million revenue and over $9 million in gross profit in Q1. The Pharmacy and Dispensary... Read more


Omnicell Announces New Products for Perioperative and Clinic Settings

RFID-Enabled Dispensing and Intelligent Inventory Management Software Aim to Unlock Greater Inventory Accuracy and Streamline Medication Management in Operating Rooms and Outpatient Clinics FORT WORTH, Texas / May 14, 2025 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced new products designed to streamline workflows and enhance inventory visibility... Read more


Schrödinger to Present Phase 1 Clinical Data on MALT1 Inhibitor SGR-1505 at EHA Annual Congress and International Conference on Malignant Lymphoma

Company to host webcast to review data on Thursday, June 12, 2025 at 8:00 a.m. ET NEW YORK / May 14, 2025 / Business Wire / Schrödinger, Inc. (Nasdaq: SDGR) today announced that initial Phase 1 clinical data for SGR-1505, its investigational MALT1 inhibitor, will be presented at the European Hematology Association Annual Congress, taking place June 12 - 15, 2025, in Milan, Italy. Additional data from this trial will be presented at the International Conference on Malignant... Read more


WELL Health Technologies Reports Record Revenue in Q1-2025 with 32% YoY Growth and Record Quarterly EBITDA in Canadian Business

WELL achieved record quarterly revenues of $294.1 million in Q1-2025, an increase of 32%(2) as compared to Q1-2024 driven by organic growth and acquisitions. Revenue was negatively impacted by a net of $6.5 million related to the delay of revenue recognition for Circle Medical. Excluding this impact, quarterly revenue was $300.7 million. WELL achieved Adjusted EBITDA(1) of $27.6 million in Q1-2025, an increase of 36%(2) as compared to Q1-2024. This figure was negatively... Read more


Newtopia Completes $2 Million Debt Financing, Assignment of Existing Senior Secured Credit Facility and Provides Corporate Update

Existing senior secured credit facility assigned to new investors; added $1.6 million of new senior secured financing, and settled $0.4 million owing to officers and directors for no cash consideration Moving towards cash flow positive status within calendar 2025 Supports Newtopia's ability to facilitate sustainable metabolic health outcomes, proven cost savings and demonstrated positive ROI to GLP-1 sponsors Highly scalable alongside the rise of Health AI: unique... Read more


Marpai Reports First Quarter 2025 Financial Results

Marpai's turnaround momentum is building TAMPA, Fla., May 14, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services, announced financial results for the first quarter of 2025. The Company expects to hold a webcast to discuss the results on May 15, 2025. Marpai CEO Damien Lamendola commented, "Our consistent double-digit success in cutting operating... Read more


Nutex Health Reports First Quarter 2025 Financial Results

TOTAL REVENUE OF $211.8 MILLION VERSUS $67.5 MILLION IN Q1 2024, AN INCREASE OF 213.8% NET INCOME ATTRIBUTABLE TO NUTEX HEALTH INC. OF $14.6 MILLION VERSUS NET LOSS OF $0.4 MILLION IN Q1 2024 DILUTED EPS OF $2.56 PER SHARE VERSUS $(0.08) PER SHARE IN Q1 2024 EBITDA OF $43.1 MILLION VERSUS $7.1 MILLION IN EBITDA IN Q1 2024, AN INCREASE OF 507.0% ADJUSTED EBITDA OF $72.8 MILLION VERSUS $(0.4) MILLION IN Q1 2024 NET CASH FROM OPERATING ACTIVITIES OF $51.0 MILLION COMPANY... Read more


GE HealthCare Announces FDA Approval of Pediatric Indication for Optison Ultrasound Enhancing Agent

The latest approval will help provide clearer echocardiogram images for cardiologists to diagnose heart conditions in pediatric patients Optison is the only polyethylene glycol (PEG)-free ultrasound enhancing agent available in the U.S. ARLINGTON HEIGHTS, Ill. / May 13, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced the U.S. Food and Drug Administration (FDA) has approved a pediatric indication for the company’s Optison™ (Perflutren Protein-Type... Read more


Premier named as data source in HealthVerity Marketplace™ to expand real-world data access for life sciences research

Integration delivers high-value datasets including chargemaster, laboratory results and EMR data to accelerate clinical and commercial insights PHILADELPHIA, May 13, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange, today announced the addition of Premier, Inc. (NASDAQ: PINC) to HealthVerity Marketplace™, meaning life sciences organizations using HealthVerity Marketplace™ can now access Premier's... Read more


GE HealthCare and Raydiant Oximetry accelerate innovation in fetal oxygen saturation technology

The companies plan to co-develop solutions that support the integration of Raydiant Oximetry’s fetal pulse oximetry technology into GE HealthCare’s fetal monitoring and digital perinatal surveillance platforms that have a 60-year history of innovation and industry firsts. Fetal pulse oximetry technology aims to provide real-time insights to clinicians during labor and delivery and improve the detection of fetal distress, potentially reducing newborn neurological injuries,... Read more


HEALWELL AI Reports Record Revenue Growth of 208% in Q1-2025 Including Record Growth of 224% in AI and Data Science Revenue

HEALWELL achieved quarterly revenue from continuing operations of $14.1 million in Q1-2025, 208% higher than the $4.6 million generated in Q1-2024. Revenue growth was driven by acquisitions in the past year and record growth of 224% in the Company's AI and Data Science business. On April 1, 2025, HEALWELL completed the acquisition of Orion Health, which is expected to contribute approximately $100 million in annual SaaS and services revenue starting in Q2-2025 and propels... Read more


Ensign to Present at the 2025 RBC Capital Markets Global Healthcare Conference

SAN JUAN CAPISTRANO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it will participate in the 2025 RBC Capital Markets Global Healthcare Conference on May 20, 2025. Barry... Read more


Waystar Announces Proposed Public Offering of Common Stock

LEHI, Utah and LOUISVILLE, Ky., May 13, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY) ("Waystar"), a provider of leading healthcare payments software, today announced a proposed underwritten public offering of 12,500,000 shares of its common stock being offered by certain investment funds of EQT AB and Bain Capital, LP, and Canada Pension Plan Investment Board (CPP Investments), and their respective affiliates (collectively, the "Selling Stockholders"). Additionally,... Read more


UnitedHealth Announces Leadership Transition

Stephen J. Hemsley named Chief Executive Officer Company suspends 2025 outlook as medical expenditures expected to be higher than anticipated Company expects to return to growth in 2026 - / May 13, 2025 / Business Wire / UnitedHealth Group (NYSE: UNH) today announced the appointment of Stephen J. Hemsley as its chief executive officer, effective immediately, following Andrew Witty’s decision to step down as CEO for personal reasons. Hemsley, who served as company... Read more


Marpai Hires Dallas Scrip As Chief Operating Officer

Marpai Bolsters Leadership Team to Drive Profitable High-Growth Strategy with Key Executive Appointment  TAMPA, Fla., May 13, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services, today announced a significant addition to its leadership team with the appointment of Dallas Scrip as Chief Operating Officer (COO) and President of MarpaiRx. This strategic... Read more


iCAD Reports Financial Results for First Quarter Ended March 31, 2025

NASHUA, N.H., May 13, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the three months ended March 31, 2025.  First Quarter 2025 Highlights (Year over Year Performance): Total ARR (Annual Recurring Revenue) was $10.7 million, up 1... Read more


SunLink Health Systems Announces Fiscal 2025 Third Quarter Results

ATLANTA / May 13, 2025 / Business Wire / SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $630,000 (or a loss of $0.09 per fully diluted share) for its third fiscal quarter ended March 31, 2025 compared to a loss from continuing operations of $824,000 (or a loss of $0.12 per fully diluted share) for the third fiscal quarter ended March 31, 2025. Net loss for the quarter ended March 31, 2025 was $671,000 (or a loss of $0.10... Read more


Encompass Health announces preliminary plans to build a 50-bed inpatient rehabilitation hospital in Apollo Beach, Florida

BIRMINGHAM, Ala. and APOLLO BEACH, Fla., May 12, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced preliminary plans to build a freestanding, 50-bed inpatient rehabilitation hospital in the master-planned community of Waterset in Apollo Beach, Florida. The hospital will serve patients recovering from debilitating illnesses and injuries, including strokes and other neurological disorders, brain injuries, spinal cord injuries, amputations and complex... Read more


Universal Health Services To Present At Healthcare Conferences

KING OF PRUSSIA, Pa., May 12, 2025 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will present at the following healthcare conferences: May 21, 2025 at 10:00am (ET) at The 2025 RBC Capital Markets GlobalHealthcare Conference June 9, 2025 at 8:00am (ET) at the 46th Annual Goldman Sachs GlobalHealthcare Conference Live audio webcasts of the presentations will be available... Read more


Acadia Healthcare Reports First Quarter 2025 Results

Affirms Full Year 2025 Guidance FRANKLIN, Tenn. / May 12, 2025 / Business Wire / Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Revenue totaled $770.5 million, compared with $768.1 million for the first quarter of 2024 Same facility revenue increased 2.1% compared with the first quarter of 2024, including an increase in... Read more


DaVita 1st Quarter 2025 Results

DENVER, May 12, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2025. "Our strong first quarter performance demonstrates the stability and consistency of our operating model" said Javier Rodriguez, CEO of DaVita Inc. "We maintain a steadfast commitment to being the provider, employer and partner of choice and returning value to our shareholders." Financial and operating highlights for the quarter... Read more


OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

Q1 revenue of $21.9 million, increasing 11% year-over-year Q1 gross profit increased 9% year-over-year to $13.3 million Increases full year 2025 guidance to a revenue range between $101 million and $106 million and adjusted EBITDA range between $13 million and $15 million WALTHAM, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach... Read more


Progyny to Present at BofA Securities 2025 Health Care Conference

NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that Progyny’s Chief Executive Officer, Pete Anevski, and Chief Financial Officer, Mark Livingston, will participate in a fireside chat at the BofA Securities 2025 Health Care Conference on Wednesday, May 14, 2025, at 3:00 P.M. Pacific Time / 6:00 P.M. Eastern Time. A live audiocast and replay will be available from... Read more


Sonida Senior Living Announces First Quarter 2025 Results

DALLAS / May 12, 2025 / Business Wire / Sonida Senior Living, Inc. (the “Company,” “Sonida,” “we,” “our,” or “us”) (NYSE: SNDA), a leading owner, operator and investor of senior housing communities, today announced its results for the first quarter ended March 31, 2025. “Sonida’s strong execution on its organic and inorganic growth strategy plan continued to bear meaningful results in the first quarter, driven by improvements in key metrics. Year-over-year... Read more